Although AD, PD and FTD are often defined by specific pathological hallmarks such as amyloid-beta (Aβ) and tau in AD1, alpha-synuclein in PD2 and tau, TDP-43 or FUS in FTD3, there is clinical and neuropathological overlap across these diseases. This evidence concerns the gene MAPT and Alzheimer disease.